A New Choice for the Use of the Stents for Transjugular Intrahepatic Portosystemic Shunt Creation: Viabahn ePTFE covered stent/bare metal stent combination

Background Compare the clinical outcome of structure and function between insertion of transjugular intrahepatic portosystemic shunt (TIPS) created with the Viabahn ePTFE covered stent/bare metal stent (BMS) combination and Fluency ePTFE covered stent/BMS combination. Methods 101 consecutive patients undergone TIPS procedure from February 2016 to August 2018 in our center were analyzed retrospectively, 64 subjects were enrolled in Viabahn group and 37 were Fluency group. We caculated the TIPS geometry characteristics and evaluated the related occurrence of shunt dysfunction, survival, overt hepatic encephalopathy (OHE) and variceal rebleeding. Results The technical success rate was 100%. After TIPS insertion, the rate of shunt dysfunction during the first 3 months was significantly different between Viabahn group and Fluency group, which were respectively 1.6% and 13.5% (p = 0.024). And multivariate analysis indicated that the angle of portalvenous inflow (α) (HR = 1.060, 95%CI = 1.009–1.112, p = 0.020) was the only predictor of shunt dysfunction. Besides, after 3 months following TIPS insertion, the α angle distinctly increased from 20.9°±14.3° to 26.9°±20.1° (p = 0.005) in Fluency group but stayed unchanged in Viabahn group (from 21.9°±15.1° to 22.9°±17.6°, p = 0.798). Conclusions The occurence of shunt dysfunction was related to the angle of portalvenous inflow (α), because of the slighter effect on α angle, after TIPS inplanation, Viabahn ePTFE covered stent/BMS combination was more stable in structure and promised higher short-term stent patency compared to Fluency ePTFE covered stent/BMS combination.

[1]  C. Zheng,et al.  Transjugular Intrahepatic Portosystemic Shunt Placement in Patients with Schistosomiasis-Induced Liver Fibrosis , 2019, CardioVascular and Interventional Radiology.

[2]  C. Zheng,et al.  Using transjugular intrahepatic portosystemic shunt as the first‐line therapy in secondary prophylaxis of variceal hemorrhage , 2019, Journal of gastroenterology and hepatology.

[3]  D. Fan,et al.  TIPSS for variceal bleeding in patients with idiopathic non‐cirrhotic portal hypertension: comparison with patients who have cirrhosis , 2019, Alimentary pharmacology & therapeutics.

[4]  Kathryn J Fowler,et al.  The Feasibility of Using Volumetric Phase-Contrast MR Imaging (4D Flow) to Assess for Transjugular Intrahepatic Portosystemic Shunt Dysfunction. , 2018, Journal of vascular and interventional radiology : JVIR.

[5]  Yu-Hua Li,et al.  Predictors of Shunt Dysfunction and Overall Survival in Patients with Variceal Bleeding Treated with Transjugular Portosystemic Shunt Creation Using the Fluency Stent Graft. , 2018, Academic radiology.

[6]  Li-hong Yang,et al.  Long-term shunt patency and overall survival of transjugular intrahepatic portosystemic shunt placement using covered stents with bare stents versus covered stents alone. , 2018, Clinical radiology.

[7]  S. Kim,et al.  An Algorithm for Management After Transjugular Intrahepatic Portosystemic Shunt Placement According to Clinical Manifestations , 2017, Digestive Diseases and Sciences.

[8]  U. Steinseifer,et al.  Evaluation of cover effects on bare stent mechanical response. , 2016, Journal of the mechanical behavior of biomedical materials.

[9]  J. Luan,et al.  Construction of Transjugular Intrahepatic Portosystemic Shunt: Bare Metal Stent/Stent-graft Combination versus Single Stent-graft, a Prospective Randomized Controlled Study with Long-term Patency and Clinical Analysis , 2016, Chinese medical journal.

[10]  D. Sze,et al.  Complications During Transjugular Intrahepatic Portosystemic Shunt Creation. , 2016, Techniques in vascular and interventional radiology.

[11]  C. Fimmel,et al.  Post-Transjugular Intrahepatic Portosystemic Shunt Follow-Up and Management in the VIATORR Era. , 2016, Techniques in vascular and interventional radiology.

[12]  Zhi-bo Xiao,et al.  Efficacy of covered and bare stent in TIPS for cirrhotic portal hypertension: A single-center randomized trial , 2016, Scientific Reports.

[13]  S. Bhatia,et al.  An Approach to Endovascular and Percutaneous Management of Transjugular Intrahepatic Portosystemic Shunt (TIPS) Dysfunction: A Pictorial Essay and Clinical Practice Algorithm , 2016, CardioVascular and Interventional Radiology.

[14]  S. Stavropoulos,et al.  Long-Term Patency and Clinical Analysis of Expanded Polytetrafluoroethylene-Covered Transjugular Intrahepatic Portosystemic Shunt Stent Grafts. , 2015, Journal of vascular and interventional radiology : JVIR.

[15]  M. Lungren,et al.  Transjugular Intrahepatic Portosystemic Shunt Complications: Prevention and Management , 2015, Seminars in Interventional Radiology.

[16]  R. de Franchis Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension. , 2015, Journal of hepatology.

[17]  J. Talwalkar,et al.  Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the European Association for the Study of the Liver and the American Association for the Study of Liver Diseases. , 2014, Journal of hepatology.

[18]  Zhiping Yang,et al.  Selection of a TIPS stent for management of portal hypertension in liver cirrhosis: an evidence-based review. , 2014, World journal of gastroenterology.

[19]  B. Giraudeau,et al.  Covered vs. uncovered stents for transjugular intrahepatic portosystemic shunt: a randomized controlled trial. , 2014, Journal of hepatology.

[20]  M. Rössle TIPS: 25 years later. , 2013, Journal of hepatology.

[21]  Xuefeng Luo,et al.  Stent-grafts for the treatment of TIPS dysfunction: fluency stent vs Wallgraft stent. , 2013, World journal of gastroenterology.

[22]  Ulrike Stampfl,et al.  Technical and clinical outcome of transjugular intrahepatic portosystemic stent shunt: bare metal stents (BMS) versus viatorr stent-grafts (VSG). , 2012, European journal of radiology.

[23]  E. Tsochatzis,et al.  Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis , 2012, Liver international : official journal of the International Association for the Study of the Liver.

[24]  D. Fan,et al.  Patency and clinical outcomes of transjugular intrahepatic portosystemic shunt with polytetrafluoroethylene‐covered stents versus bare stents: A meta‐analysis , 2010, Journal of gastroenterology and hepatology.

[25]  M. Davies,et al.  Stent-grafts for transjugular intrahepatic portosystemic shunt creation: specialized TIPS stent-graft versus generic stent-graft/bare stent combination. , 2010, Journal of vascular and interventional radiology : JVIR.

[26]  J. Lopera,et al.  Causes of TIPS dysfunction. , 2008, AJR. American journal of roentgenology.

[27]  T. Clark Management of shunt dysfunction in the era of TIPS endografts. , 2008, Techniques in vascular and interventional radiology.

[28]  M. Cejna Should stent-grafts replace bare stents for primary transjugular intrahepatic portosystemic shunts? , 2005, Seminars in interventional radiology.

[29]  J. Palmaz Transjugular intrahepatic portosystemic shunt. , 2020, Clinical privilege white paper.

[30]  P. Kamath,et al.  Transjugular intrahepatic portosystemic shunts: an update , 2003, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[31]  A. Roberts,et al.  Quality improvement guidelines for transjugular intrahepatic portosystemic shunts. , 2003, Journal of vascular and interventional radiology : JVIR.

[32]  P. Rosenthal,et al.  American Association for the Study of Liver Diseases , 1993, IDrugs : the investigational drugs journal.

[33]  T. Pilgram,et al.  Doppler sonography findings associated with transjugular intrahepatic portosystemic shunt malfunction. , 1997, AJR. American journal of roentgenology.